Advanced search
Publication Cover
Gut Microbes Volume 13, 2021 - Issue 1
Submit an article Journal homepage
4,702
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis

Yongguo Zhanga Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USAView further author information
,
Destiny Ogbua Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USAView further author information
,
Shari Garretta Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USAView further author information
,
Yinglin Xiaa Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USAView further author information
&
Jun Suna Department of Microbiology/Immunology, University of Illinois at Chicago, Chicago, USA;b Department of Medicine, Jesse Brown Va Medical Center, Chicago, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7465-3133View further author information
ORCID Icon
Article: 1996848 | Received 11 Aug 2021, Accepted 08 Oct 2021, Published online: 23 Nov 2021

References

  • Turner MR, Chohan G, Quaghebeur G, Greenhall RC, Hadjivassiliou M, Talbot K. A case of celiac disease mimicking amyotrophic lateral sclerosis. Nat Clin Pract Neurol. 2007;3:581–25. doi:10.1038/ncpneuro0631.
  • Brown KJ, Jewells V, Herfarth H, Castillo M. White matter lesions suggestive of amyotrophic lateral sclerosis attributed to celiac disease. AJNR Am J Neuroradiol. 2010;31(5):880–881. doi:10.3174/ajnr.A1826.
  • Ham H, Lee BI, Oh HJ, Park SH, Kim JS, Park JM, Cho YS, Choi MG. A case of celiac disease with neurologic manifestations misdiagnosed as amyotrophic lateral sclerosis. Intest Res. 2017;15:540–542. doi:10.5217/ir.2017.15.4.540.
  • Gadoth A, Nefussy B, Bleiberg M, Klein T, Artman I, Drory VE. Transglutaminase 6 antibodies in the serum of patients with amyotrophic lateral sclerosis. JAMA Neurol. 2015;72:676–681. doi:10.1001/jamaneurol.2015.48.
  • Zhang R, Miller RG, Gascon R, Champion S, Katz J, Lancero M, Narvaez A, Honrada R, Ruvalcaba D, McGrath MS. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2009;206:121–124. doi:10.1016/j.jneuroim.2008.09.017.
  • Tortelli R, Zecca C, Piccininni M, Benmahamed S, Dell'Abate MT, Barulli MR, Capozzo R, Battista P, Logroscino G. Plasma inflammatory cytokines are elevated in ALS. Front Neurol. 2020;11:552295. doi:10.3389/fneur.2020.552295.
  • Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 2013;81:1222–1225. doi:10.1212/WNL.0b013e3182a6cc13.
  • Zhang YG, Wu S, Yi J, Xia Y, Jin D, Zhou J, Sun J. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017;39:322–336. doi:10.1016/j.clinthera.2016.12.014.
  • Wu S, Yi J, Zhang YG, Zhou J, Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol Rep. 2015:3(4):e12356. doi:10.14814/phy2.12356.
  • Rowin J, Xia Y, Jung B, Sun, J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol Rep. 2017:5(18):e13443.doi:10.14814/phy2.13443.
  • Fang X, Wang X, Yang S, Meng F, Wang X, Wei H, Chen T. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front Microbiol. 2016;7:1479. doi:10.3389/fmicb.2016.01479.
  • Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572(7770):474–480. doi:10.1038/s41586-019-1443-5.
  • Burberry A, Wells MF, Limone F, Couto A, Smith KS, Keaney J, Gillet G, van Gastel N, Wang JY, Pietilainen O, et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89–94. doi:10.1038/s41586-020-2288-7.
  • Di Gioia D, Bozzi Cionci N, Baffoni L, Amoruso A, Pane M, Mogna L, Gaggìa F, Lucenti MA, Bersano E, Cantello R, et al. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC Med. 2020;18:153. doi:10.1186/s12916-020-01607-9.
  • Figueroa-Romero C, Guo K, Murdock BJ, Paez-Colasante X, Bassis CM, Mikhail KA, Raue KD, Evans MC, Taubman GF, McDermott AJ, et al. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Dis Model Mech. 2019:13(2):dmm041947. doi:10.1242/dmm.041947.
  • Niccolai E, Di Pilato V, Nannini G, Baldi S, Russo E, Zucchi E, Martinelli I, Menicatti M, Bartolucci G, Mandrioli J et al. The gut microbiota-immunity axis in ALS: a role in deciphering disease heterogeneity? Biomedicines. 2021:9(7):753. doi:10.3390/biomedicines9070753.
  • Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM. Colonic bacterial composition in parkinson’s disease. Mov Disorders. 2015;30:1351–1360. doi:10.1002/mds.26307.
  • Dey N, Wagner VE, Blanton LV, Cheng J, Fontana L, Haque R, Ahmed T, Gordon JI. Regulators of gut mobility revealed by a gnotobiotic model of diet-microbiome interactions related to travel. Cell. 2015;163:95–107. doi:10.1016/j.cell.2015.08.059.
  • Husebye E, Hellstrom PM, Midtvedt T. Intestinal microflora stimulates myoelectric activity of rat small intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex. Dig Dis Sci. 1994;39(5):946–956. doi:10.1007/BF02087542.
  • Whorwell PJ, McCallum M, Creed FH, Roberts CT. Non-colonic features of irritable bowel syndrome. Gut. 1986;27:37–40. doi:10.1136/gut.27.1.37.
  • Patel A, Harker N, Moreira-Santos L, Ferreira M, Alden K, Timmis J, Foster K, Garefalaki A, Pachnis P, Andrews P, et al. Differential RET signaling pathways drive development of the enteric lymphoid and nervous systems. Sci Signal. 2012;5:ra55. doi:10.1126/scisignal.2002734.
  • Vanner S, Greenwood-Van Meerveld B, Mawe G, Shea-Donohue T, Verdu EF, Wood J, Grundy D. Fundamentals of neurogastroenterology: basic science. Gastroenterology 2016;18: S0016-5085(16)00184-0 . . doi:10.1053/j.gastro.2016.02.018.
  • Niesler B, Kuerten S, Demir IE, Schäfer KH. Disorders of the enteric nervous system - a holistic view. Nat Rev Gastroenterol Hepatol 2021;18(6):393-410. doi:10.1038/s41575-020-00385-2. .
  • Rao M, Gershon MD. The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol. 2016;13(9):517–528. doi:10.1038/nrgastro.2016.107.
  • Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772–1775. doi:10.1126/science.8209258.
  • Philips T, and Rothstein JD. Rodent models of amyotrophic lateral sclerosis. Curr Protoc Pharmacol. 2015;69(1):5.67.1-5.67.21. doi:10.1002/0471141755.ph0567s69.
  • Deng HX, Shi Y, Furukawa Y, Zhai H, Fu R, Liu E, Gorrie GH, Khan MS, Hung WY, Bigio EH, et al. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci U S A. 2006;103:7142–7147. doi:10.1073/pnas.0602046103.
  • Wu S, Zhang YG, Lu R, Xia Y, Zhou D, Petrof EO, Claud EC, Chen D, Chang EB, Carmeliet G, et al . Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis. Gut. 2015;64:1082–1094. doi:10.1136/gutjnl-2014-307436.
  • Lu R, Zhang YG, Xia Y, Zhang J, Kaser A, Blumberg R, Sun J. Paneth cell alertness to pathogens maintained by Vitamin D receptors. Gastroenterology. 2021;160:1269–1283. doi:10.1054/j.gastro.2020.11.015.
  • Zhang YG, Lu R, Wu S, Chatterjee I, Zhou D, Xia Y, Sun J. Vitamin D receptor protects against dysbiosis and tumorigenesis via the JAK/STAT pathway in intestine. Cell Mol Gastroenterol Hepatol. 2020;10(4):729–746. doi:10.1017/j.jcmgh.2020.05.010.
  • Naqib A, Poggi S, Wang W, Hyde M, Kunstman K, Green SJ. Making and Sequencing Heavily Multiplexed, High-Throughput 16S Ribosomal RNA Gene Amplicon Libraries Using a Flexible, Two-Stage PCR Protocol. In: Raghavachari N, and Garcia-Reyero N, editors. Gene Expression Analysis: methods and Protocols. New York: Springer New York; 2018. p. 149–169.
  • Zhang J, Kobert K, Flouri T, Stamatakis A. PEAR: a fast and accurate illumina paired-end reAd mergeR. Bioinformatics. 2013;30:614–620. doi:10.1093/bioinformatics/btt593.
  • Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26(19):2460–2461. doi:10.1093/bioinformatics/btq461.
  • Glöckner FO, Yilmaz P, Quast C, Gerken J, Beccati A, Ciuprina A, Bruns G, Yarza P, Peplies J, Westram R, et al. 25 years of serving the community with ribosomal RNA gene reference databases and tools. J Biotechnol. 2017;261:17–169. doi:10.1016/j.jbiotec.2017.06.1198.
  • Xia Y, Sun J, and Chen D-G. Statistical analysis of microbiome data with R. Singapore: Springer Singapore; 2018.
  • Zhang X, Yi N. Fast zero-inflated negative binomial mixed modeling approach for analyzing longitudinal metagenomics data. Bioinformatics. 2020;36:2345–2351. doi:10.1094/bioinformatics/btz973.
  • Pinheiro J, Bates D. Mixed-Effects Models in S and S-PLUS. New York, NY: Springer-Verlag New York, Inc.; 2000.
  • Pinheiro J, Bates D. Mixed-effects models in S and S-PLUS. Springer Science & Business Media; 2006.
  • Nagakura Y, Naitoh Y, Kamato T, Yamano M, Miyata K. Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice. Eur J Pharmacol. 1996;311:67–72. doi:10.1016/0014-2999(96)00403-7.
  • Xu Z, Chen S, Li X, Luo G, Li L, Le W. Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res. 2006;31:1263–1269. doi:10.1007/s11064-006-9166-z.
  • Wedel T, Van Eys GJ, Waltregny D, Glénisson W, Castronovo V, Vanderwinden JM. Novel smooth muscle markers reveal abnormalities of the intestinal musculature in severe colorectal motility disorders. Neurogastroenterol Motil. 2006;18:526–538. doi:10.1111/j.1365-2982.2006.00781.x.
  • Sharkey KA. Emerging roles for enteric glia in gastrointestinal disorders. J Clin Invest. 2015;125(3):918–925. doi:10.1172/JCI76303.
  • Rao M, Rastelli D, Dong L, Chiu S, Setlik W, Gershon MD, Corfas G. Enteric glia regulate gastrointestinal mobility but are not required for maintenance of the epithelium in mice. Gastroenterology. 2017;153:1068–1081 e7. doi:10.1053/j.gastro.2017.07.002.
  • Sidebotham EL, Woodward MN, Kenny SE, Lloyd DA, Vaillant CR, Edgar DH. Assessment of protein gene product 9.5 as a marker of neural crest-derived precursor cells in the developing enteric nervous system. Pediatr Surg Int. 2001;17:304–307. doi:10.1007/s003830100599.
  • Linninge C, Ahrne S, Molin G. Pre-treatment with antibiotics and escherichia coli to equalize the gut microbiota in conventional mice. Antonie Van Leeuwenhoek. 2015;107(1):149–156. doi:10.1007/s10482-014-0312-3.
  • Zhang YG, and Sun J. . Organoids: Stem cells, structure and function. 2019 Study host-bacterial interactions using intestinal organoids 1576 Turksen, K Methods Mol Biol (New York, NY: Humana PRE) :249–254 doi:10.1007/7651_2016_6.
  • Zhang YG, Wu S, Xia Y, Sun J. Salmonella-infected crypt-derived intestinal organoid culture system for host-bacterial interactions. Physiol Rep. 2014:2(9):e12147. doi:10.14814/phy2.12147.
  • Zhang YG, Lu R, Wu S. Vitamin D receptor protects against dysbiosis and tumorigenesis via the JAK/STAT pathway in intestine. Cell Mol Gastroenterol Hepatol. 2020;10:729–746. doi:10.1016/j.jcmgh.2020.05.010.
  • Lu R, Zhang YG, Xia Y. Paneth cell alertness to pathogens maintained by Vitamin D receptors. Gastroenterology. 2021;160:1269–1283. doi:10.1053/j.gastro.2020.11.015.
  • Zhang X, Yi N. Fast zero-inflated negative binomial mixed modeling approach for analyzing longitudinal metagenomics data. Bioinformatics. 2020;36:2345–2351. doi:10.1093/bioinformatics/btz973.
  • Sczesnak A, Segata N, Qin X, Gevers D, Petrosino JF, Huttenhower C, Littman DR, Ivanov II. The genome of th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment. Cell Host Microbe. 2011;10:260–272. doi:10.1016/j.chom.2011.08.005.
  • La Rosa SL, Leth ML, Michalak L, Hansen ME, Pudlo NA, Glowacki R, Pereira G, Workman CT, Arntzen MØ, Pope PB et al. The human gut firmicute roseburia intestinalis is a primary degrader of dietary beta-mannans. Nat Commun. 2019;10:905. doi:10.1038/s41467-019-08812-y.
  • Clavel T, Charrier C, Braune A, Wenning M, Blaut M, Haller D. Isolation of bacteria from the ileal mucosa of TNFdeltaARE mice and description of enterorhabdus mucosicola gen. nov., sp. nov. Int J Syst Evol Microbiol. 2009;59:1805–1812. doi:10.1099/ijs.0.003087-0.
  • Wu W, Liu HP, Chen F, Liu H, Cao AT, Yao S, Sun M, Evans-Marin HL, Zhao Y, Zhao Q, et al. Commensal A4 bacteria inhibit intestinal Th2-cell responses through induction of dendritic cell TGF-beta production. Eur J Immunol. 2016;46:1162–1167. doi:10.1002/eji.201546160.
  • Biggs MB, Medlock GL, Moutinho TJ, Lees HJ, Swann JR, Kolling GL, Papin JA. Systems-level metabolism of the altered schaedler flora, a complete gut microbiota. ISME J. 2017;11:426–438. doi:10.1038/ismej.2016.130.
  • Loubinoux J, Bronowicki JP, Pereira IA, Mougenel JL, Faou AE. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol Ecol. 2002;40:107–112. doi:10.1111/j.1574-6941.2002.tb00942.x.
  • Nezami BG, Srinivasan S. Enteric nervous system in the small intestine: pathophysiology and clinical implications. Curr Gastroenterol Rep. 2010;12(5):358–365. doi:10.1007/s11894-010-0129-9.
  • Hatzipetros T, Bogdanik LP, Tassinari VR, Kidd JD, Moreno AJ, Davis C, Osborne M, Austin A, Vieira FG, Lutz C, et al. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res. 2014;1584:59–72. doi:10.1016/j.brainres.2013.10.013.
  • Camilleri M, Bharucha AE. Gastrointestinal dysfunction in neurologic disease. Semin Neurol. 1996;16(03):203–216. doi:10.1055/s-2008-1040977.
  • Swanson PA 2nd, Kumar A, Samarin S, Vijay-Kumar M, Kundu K, Murthy N, Hansen J, Nusrat A, Neish AS. Enteric commensal bacteria potentiate epithelial restitution via reactive oxygen species-mediated inactivation of focal adhesion kinase phosphatases. Proc Natl Acad Sci U S A. 2011;108:8803–8808. doi:10.1073/pnas.1010042108.
  • Becker L, Nguyen L, Gill J, Kulkarni S, Pasricha PJ, Habtezion A. Age-dependent shift in macrophage polarisation causes inflammation-mediated degeneration of enteric nervous system. Gut 2017;67 (5):827-836 doi:10.1136/gutjnl-2016-312940 .
  • Xu HM, Huang HL, Zhou YL, Zhao HL, Xu J, Shou DW, Liu YD, Zhou YJ, Nie YQ. Fecal microbiota transplantation: a new therapeutic attempt from the gut to the brain. Gastroenterol Res Pract. 2021;2021:6699268. doi:10.1155/2021/6699268.
  • Ramsauer B, Konig C, Sabelhaus T, Ockenga J, Otte JM. [Fecal microbiota transplantation in relapsing clostridium difficile colitis]. MMW Fortschr Med. 2016;158(Suppl 4):17–20. doi:10.1007/s15006-016-8305-y.
  • Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, Khoruts A, Geis E, Maldonado J, McDonough-Means S, et al. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017;5:10. doi:10.1186/s40168-016-0225-7.
  • Kang DW, Adams JB, Coleman DM, Pollard EL, Maldonado J, McDonough-Means S, Caporaso JG, Krajmalnik-Brown R. Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota. Sci Rep. 2019;9:5821. doi:10.1038/s41598-019-42183-0.
  • Huang H, Xu H, Luo Q, He J, Li M, Chen H, Tang W, Nie Y, Zhou Y. Fecal microbiota transplantation to treat parkinson’s disease with constipation: a case report. Medicine (Baltimore). 2019;98:e16163. doi:10.1097/MD.0000000000016163.
  • Sabel CE, Boyle PJ, Loytonen M, Gatrell AC, Jokelainen M, Flowerdew R, Maasilta P. Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. Am J Epidemiol. 2003;157(10):898–905. doi:10.1093/aje/kwg090.
  • Mandrioli J, Amedei A, Cammarota G, Niccolai E, Zucchi E, D'Amico R, Ricci F, Quaranta G, Spanu T, Masucci L. FETR-ALS study protocol: a randomized clinical trial of fecal microbiota transplantation in amyotrophic lateral sclerosis. Front Neurol. 2019;10:1021. doi:10.3389/fneur.2019.01021.
  • Kaneko K, Hachiya NS. Hypothesis: gut as source of motor neuron toxin in the development of ALS. Med Hypotheses. 2006;66(2):438–439. doi:10.1016/j.mehy.2005.09.012.
  • Longstreth WT Jr., Meschke JS, Davidson SK, Smoot LM, Smoot JC, Koepsell TD. Hypothesis: a motor neuron toxin produced by a clostridial species residing in gut causes ALS. Med Hypotheses. 2005;64:1153–1156. doi:10.1016/j.mehy.2004.07.041.
  • Toepfer M, Folwaczny C, Klauser A, Riepl RL, Müller-Felber W, Pongratz D. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999;1:15–19. doi:10.1080/146608299300079484.
  • Mazzini L, Marchi FD, Niccolai E, Mandrioli J, Amedei A. Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: a New Frontier for Targeting? In Araki T, editor. Amyotrophic Lateral Sclerosis. Brisbane (AU): Exon Publications; Chapter 8.2021.
  • Nubling GS, Mie E, Bauer RM, Hensler M, Lorenzl S, Hapfelmeier A, Irwin DE, Borasio GD, Winkler AS. Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:174–179. doi:10.3109/21678421.2013.868001.
  • Turnbull J. Sodium Phenylbutyrate-Taurursodiol for ALS. N Engl J Med. 2020;383:2293–2294.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.